GlaxoSmithKline logo

Corporate Executive Team (CET)

Membership

Chairman:

Andrew Witty

Members:

  • Simon Bicknell, Senior Vice President, Governance, Ethics and Assurance
  • Deirdre Connelly, President, North American Pharmaceuticals
  • Marc Dunoyer, Head of Rare Diseases Unit and Chairman of GSK Japan
  • Eddie Gray, President, Pharmaceuticals Europe
  • Simon Dingemans, Chief Financial Officer
  • Abbas Hussain, President, Emerging Markets & Asia Pacific
  • Bill Louv, Senior VP, Core Business Services and Chief Information Officer
  • David Pulman, President, Global Manufacturing and Supply
  • David Redfern, Chief Strategy Officer & Chairman, ViiV Healthcare
  • Moncef Slaoui, Chairman, Research & Development
  • Jean Stéphenne, Chairman and President, Biologicals
  • Claire Thomas, Senior Vice President, Human Resources
  • Dan Troy, Senior Vice President & General Counsel
  • Patrick Vallance, Senior Vice President, Medicines Discovery and Development
  • Phil Thomson, Senior Vice President, Global Communications
  • Emma Walmsley, President, Consumer Healthcare Worldwide

Secretary:

VP, Office of the CEO

Frequency of meetings:

The CET meets 11 times per year.

The CET assists the CEO in the executive management of the group.